| __timestamp | Ionis Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 79838000 |
| Thursday, January 1, 2015 | 322292000 | 121816000 |
| Friday, January 1, 2016 | 344320000 | 117633000 |
| Sunday, January 1, 2017 | 374644000 | 117456000 |
| Monday, January 1, 2018 | 414604000 | 171984000 |
| Tuesday, January 1, 2019 | 466000000 | 257452000 |
| Wednesday, January 1, 2020 | 535000000 | 477643000 |
| Friday, January 1, 2021 | 643000000 | 540684000 |
| Saturday, January 1, 2022 | 833000000 | 651496000 |
| Sunday, January 1, 2023 | 899625000 | 666563000 |
| Monday, January 1, 2024 | 901530000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have demonstrated significant dedication to advancing their scientific endeavors.
From 2014 to 2023, Ionis Pharmaceuticals increased its R&D expenses by approximately 272%, reflecting a robust growth trajectory. By 2023, their investment in innovation reached nearly 900 million, underscoring their strategic focus on developing cutting-edge therapies.
Similarly, PTC Therapeutics showcased a remarkable 735% increase in R&D spending over the same period. By 2023, their R&D expenses approached 667 million, highlighting their commitment to pioneering treatments.
This data not only illustrates the financial commitment of these companies but also their pivotal role in driving the future of biotechnology.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: PTC Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Viridian Therapeutics, Inc.